feed,title,long_url,short_url
SeekingAlpha,Roche's new immunotherapy tiragolumab fails main goal of phase 3 trial in lung cancer,https://seekingalpha.com/news/3818737,
SeekingAlpha,Should investors be worried about the yield curve inversion?,https://seekingalpha.com/news/3818738,
